Johnson Jeh C. 4
4 · METLIFE INC · Filed Mar 12, 2026
Research Summary
AI-generated summary of this filing
MetLife (MET) Director Jeh C. Johnson Receives 65 Shares
What Happened Jeh C. Johnson, a director of MetLife, received 65 shares of MetLife common stock on 2026-03-10 at an imputed price of $70.60 per share, for a total value of $4,589. The filing lists this as an acquisition/award (code A) and reflects an imputed reinvestment of dividends into deferred shares under MetLife’s Deferred Compensation Plan for Non-Management Directors.
Key Details
- Transaction date and price: 2026-03-10 at $70.60 per share.
- Shares acquired: 65; transaction value: $4,589.
- Filing date: 2026-03-12 (two days after the transaction).
- Shares owned after the transaction: not disclosed in the Form 4.
- Footnote: F1 — these are deferred shares created by reinvested dividends; the director deferred receipt of payable shares under the deferred compensation plan.
- Transaction code: A (award/acquisition). No 10b5-1 plan, option exercise, sale, or gift was reported.
Context This transaction reflects routine compensation and dividend reinvestment common for non-management directors rather than an open-market purchase. While acquisitions can be interpreted positively, these deferred-share awards are standard plan mechanics and do not necessarily signal a change in the director’s view of the company.
Insider Transaction Report
- Award
Common Stock
[F1]2026-03-10$70.60/sh+65$4,589→ 8,129 total
Footnotes (1)
- [F1]Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.